chr20-13048957-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018327.4(SPTLC3):āc.130C>Gā(p.Pro44Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000399 in 1,553,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018327.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTLC3 | NM_018327.4 | c.130C>G | p.Pro44Ala | missense_variant | 2/12 | ENST00000399002.7 | NP_060797.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTLC3 | ENST00000399002.7 | c.130C>G | p.Pro44Ala | missense_variant | 2/12 | 1 | NM_018327.4 | ENSP00000381968 | P1 | |
SPTLC3 | ENST00000476791.1 | n.419C>G | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
SPTLC3 | ENST00000450297.1 | c.49C>G | p.Pro17Ala | missense_variant | 2/5 | 3 | ENSP00000409125 | |||
SPTLC3 | ENST00000434210.5 | c.130C>G | p.Pro44Ala | missense_variant | 3/4 | 3 | ENSP00000389749 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000686 AC: 14AN: 204056Hom.: 0 AF XY: 0.0000725 AC XY: 8AN XY: 110382
GnomAD4 exome AF: 0.0000257 AC: 36AN: 1401430Hom.: 0 Cov.: 29 AF XY: 0.0000260 AC XY: 18AN XY: 693286
GnomAD4 genome AF: 0.000171 AC: 26AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.130C>G (p.P44A) alteration is located in exon 2 (coding exon 2) of the SPTLC3 gene. This alteration results from a C to G substitution at nucleotide position 130, causing the proline (P) at amino acid position 44 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at